Fingerprint
Dive into the research topics of 'Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer
Johnny Kao, Eric M. Genden, Chien Ting Chen, Michael Rivera, Charles C.L. Tong, Kryztof Misiukiewicz, Vishal Gupta, Vivek Gurudutt, Marita Teng, Stuart H. Packer
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations